PAR

5.00%

19.0¢ paradigm biopharmaceuticals limited..

Thanks Mozz, clear as day :-) From what I can find the next...

First 22 Last

Share
Profile

Follow
PharmD

972 Posts.

216

30/04/20

21:27

Post #: 44366767
Share

Originally posted by Mozzarc: ↑

Well if I can be so bold to butt in here, my take on it is the following advantages:

A] Exposure!

Yes a company that's outside of the Top 300 can be a bit of ho hum...but enter one of the prized cut offs like top 300...top 200 and of course top 100 and its a different exposure entirely.

B] Forced buy-in

Some large funds are simply not allowed to invest in or interested in the small fish. What's the point of a massive Insto. taking a 40% stake in us...it will simply paralyse us and stymie results potentially...leave aside the fact that the Aussie Corporations act wouldn't allow it anyway and how can they acquire such a percentage on market anyway. On the contrary some large funds are compelled to take a stake of every company in certain bands such as the Top 100 or Top 300 etc. They are forced to take an exposure to all companies in that bracket. For this reason our exposure increases. There are also fund like Vanguard, Beta Shares etc that will also be forced to take us up to some extent so that their "Aussie" exposure is maintained via their Hedged and Non Hedged Index funds. This all adds to our story.

C] Coverage

Larger companies such as those to be found in the top X bands garner more exposure and this also means more investment houses and analysts cover us. Whats the advantage of that? Well they inform their clients about us and all of a sudden we hit so many more radars. There are so many US specialist and boutique funds that will automatically start researching any new companies that hit the Top X Strata, even if they are in the Aussie market, of course this will get accelerated (in my view) once their American Footballers start talking about us and we get the exciting ensuing media coverage).

Disclaimers
I ain't a professional advisor, DYOR applies.

Expand

Thanks Mozz, clear as day From what I can find the next rebalance is 22nd June which was delayed from March because of COVID. Does this sound correct?

PAR Price at posting: $1.95 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

There are more pages in this discussion • 8 more messages in this thread...

First 22 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 19.0¢		Change -0.010(5.00%)		Mkt cap ! $66.54M

Open	High	Low	Value	Volume
20.0¢	21.0¢	19.0¢	$203.4K	1.019M

Buyers (Bids)

No.	Vol.	Price($)
14	387930	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	65468	2

View Market Depth

No.	Vol.	Price($)
13	384246	0.190
3	57000	0.185
8	194873	0.180
6	140904	0.175
7	595605	0.170

Price($)	Vol.	No.
0.205	65468	2
0.210	25992	3
0.215	30000	1
0.220	27066	4
0.225	21604	2

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PAR (ASX) Chart

Thanks Mozz, clear as day :-) From what I can find the next...

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thanks Mozz, clear as day :-) From what I can find the next...

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News